Prospects for cervical cancer prevention by human papillomavirus vaccinationSCHILLER, John T; LOWY, Douglas R.Cancer research (Baltimore). 2006, Vol 66, Num 21, pp 10229-10232, issn 0008-5472, 4 p.Article

Papillomavirus-like particle vaccinesSCHILLER, John T; LOWY, Douglas R.Journal of the National Cancer Institute. Monographs. 2000, Num 28, pp 50-54, issn 1052-6773Conference Paper

Vaccines to Prevent Infections by OncovirusesSCHILLER, John T; LOWY, Douglas R.Annual review of microbiology. 2010, Vol 64, pp 23-41, issn 0066-4227, 19 p.Article

Heparan Sulfate-Independent Cell Binding and Infection with Furin-Precleaved Papillomavirus CapsidsDAY, Patricia M; LOWY, Douglas R; SCHILLER, John T et al.Journal of virology. 2008, Vol 82, Num 24, pp 12565-12568, issn 0022-538X, 4 p.Article

Second generation HPV vaccines to prevent cervical cancerSCHILLER, John T; NARDELLI-HAEFLIGER, Denise.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.147-S3.156Article

Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccinesDA SILVA, Diane M; SCHILLER, John T; KAST, W. Martin et al.Vaccine. 2003, Vol 21, Num 23, pp 3219-3227, issn 0264-410X, 9 p.Article

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, I1-I31, SUP8Article

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 VaccineKREIMER, Aimee R; RODRIGUEZ, Ana Cecilia; LOWY, Douglas R et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 19, pp 1444-1451, issn 0027-8874, 8 p.Article

Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineNARDELLI-HAEFLIGER, Denise; LURATI, Floriana; WIRTHNER, Daniel et al.Vaccine. 2005, Vol 23, Num 28, pp 3634-3641, issn 0264-410X, 8 p.Article

Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cellsLENZ, Petra; THOMPSON, Cynthia D; DAY, Patricia M et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 106, Num 3, pp 231-237, issn 1521-6616, 7 p.Article

Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine TrialLANG KUHS, Krystle A; GONZALEZ, Paula; DELVECCHIO, Corey et al.The Journal of infectious diseases. 2014, Vol 210, Num 12, pp 1890-1899, issn 0022-1899, 10 p.Article

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protectionKEMP, Troy J; HILDESHEIM, Allan; SAFAEIAN, Mahboobeh et al.Vaccine. 2011, Vol 29, Num 11, pp 2011-2014, issn 0264-410X, 4 p.Article

A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogensTALWAR, G. P; DAR, Sajad A; BALA, Manju et al.International journal of antimicrobial agents. 2008, Vol 32, Num 2, pp 180-185, issn 0924-8579, 6 p.Article

Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancerFRANCO, Eduardo L; BOSCH, F. Xavier; CUZICK, Jack et al.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.242-S3.249Article

Efficient intracellular assembly of papillomaviral vectorsBUCK, Christopher B; PASTRANA, Diana V; LOWY, Douglas R et al.Journal of virology. 2004, Vol 78, Num 2, pp 751-757, issn 0022-538X, 7 p.Article

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particlesNARDELLI-HAEFLIGER, Denise; WIRTHNER, Daniel; SCHILLER, John T et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 15, pp 1128-1137, issn 0027-8874, 10 p.Article

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neckMORK, Jon; LIE, A. Kathrine; LEHTINEN, Matti et al.The New England journal of medicine. 2001, Vol 344, Num 15, pp 1125-1131, issn 0028-4793Article

Developing HPV virus-like particle vaccines to prevent cervical cancer : a progress reportSCHILLER, John T; HIDESHEIM, Allan.Journal of clinical virology. 2000, Vol 19, Num 1-2, pp 67-74, issn 1386-6532Conference Paper

Comprehensive Control of Human Papillomavirus Infections and Related DiseasesBOSCH, F. Xavier; BROKER, Thomas R; CUZICK, Jack et al.Vaccine. 2013, Vol 31, issn 0264-410X, H1-H31, SUP7Article

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix^®KEMP, TroyJ; SAFAEIAN, Mahboobeh; HILDESHEIM, Allan et al.Vaccine. 2012, Vol 31, Num 1, pp 165-170, issn 0264-410X, 6 p.Article

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsSCHILLER, John T; CASTELLSAGUE, Xavier; VILLA, Luisa L et al.Vaccine. Supplement. 2008, Vol 26, Num 10, issn 1359-5938, K53-K61Article

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection : A randomized trial. CommentaryHILDESHEIM, Allan; HERRERO, Rolando; JIMENEZ, Silvia E et al.JAMA, the journal of the American Medical Association. 2007, Vol 298, Num 7, issn 0098-7484, 743-753, 805-806 [13 p.]Article

A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomesKÄMPER, Nadine; DAY, Patricia M; NOWAK, Thorsten et al.Journal of virology. 2006, Vol 80, Num 2, pp 759-768, issn 0022-538X, 10 p.Article

Human papillomavirus serology and the risk of esophageal and gastric cancers : Results from a cohort in a high-risk region in ChinaKAMANGAR, Farin; QIAO, You-Lin; SCHILLER, John T et al.International journal of cancer. 2006, Vol 119, Num 3, pp 579-584, issn 0020-7136, 6 p.Article

HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodPINTO, Ligia A; CASTLE, Philip E; BERZOFSKY, Jay A et al.Vaccine. 2005, Vol 23, Num 27, pp 3555-3564, issn 0264-410X, 10 p.Article